Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Development of clinical trials and biobanks

Prof Hani Gabra – Imperial College London, UK
Development of clinical trials and biobanks  ( Prof Hani Gabra – Imperial College London, UK )
15 Nov 2012

Biology of molecular sub types in ovarian cancer

Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia
Biology of molecular sub types in ovarian cancer ( Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia )
15 Nov 2012

New genetic sub-types of breast, ovarian and prostate cancer

Dr Paul Pharoah – University of Cambridge, UK
New genetic sub-types of breast, ovarian and prostate cancer ( Dr Paul Pharoah – University of Cambridge, UK )
14 Nov 2012

New therapies to treat advanced endometrial cancer

Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA
New therapies to treat advanced endometrial cancer ( Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA )
29 Oct 2012

Defining and advancing individualised medicine

Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA
Defining and advancing individualised medicine ( Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA )
29 Oct 2012

6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics

Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith
6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics ( Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith )
23 Oct 2012

A multi-discipline approach to personalised medicine

Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member
A multi-discipline approach to personalised medicine ( Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member )
22 Oct 2012

Challenges to the development of personalised medicine

Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC
Challenges to the development of personalised medicine ( Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC )
22 Oct 2012

Development of oncology policy

Prof Jose Mariano Gago – ECCO Political Advisor
Development of oncology policy ( Prof Jose Mariano Gago – ECCO Political Advisor )
22 Oct 2012

The role of patients in personalised medicine development

Ian Banks – ECCO Patient Advisory Committee; Jan Geissler – ECCO Patient Advisory committee
The role of patients in personalised medicine development ( Ian Banks – ECCO Patient Advisory Committee; Jan Geissler – ECCO Patient Advisory committee )
22 Oct 2012

Progress of personalised oncology treatment

Prof Martine Piccart – President-Elect of ECCO
Progress of personalised oncology treatment ( Prof Martine Piccart – President-Elect of ECCO )
22 Oct 2012

Role of ECCO in the development of personalised oncology treatment

Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO
Role of ECCO in the development of personalised oncology treatment ( Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO )
22 Oct 2012